Comments on the Salmeterol Multicenter Asthma Research Trial [7]

Chest

Volumn 130, Issue 3, 2006, Pages 930-931

  Seymour, Sally M ^a   Sullivan, Eugene J ^a   Chowdhury, Badrul A ^a   Meyer, Robert J ^a   Davi, Ruthanna C ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALMETEROL; SALMETEROL XINAFOATE;

ASTHMA; CLINICAL TRIAL; DATA ANALYSIS; DRUG RESEARCH; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33748866632     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.3.930     Document Type: Letter

References (4)

1. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial. Chest 2006; 129:15-26
2. Cast W, Fuller R, Hall J, et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306:1034-1037
3. US FDA Pulmonary-Allergy Drugs Advisory Committee Meeting, July 13, 2005. Available at: http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4148T1. htm. Accessed March 27, 2006
4. US FDA drug information. Serevent Diskus, Advair Diskus, and Foradil information. Available at: http://www.fda.gov/cder/drug/infopage/LABA/default. htm. Accessed March 27, 2006